Corrigendum to “The optimization of fluorescence imaging of brain tumor tissue differentiated from brain edema-in vivo kinetic study of 5-aminolevulinic acid and talaporfin sodium” [Photodiagn. Photodyn. Ther. 6(1) (2009), 19–27](S1572100009000325)(10.1016/j.pdpdt.2009.03.005);The optimization of fluorescence imaging of brain tumor tissue differentiated from brain edema-In vivo kinetic study of 5-aminolevulinic acid and talaporfin sodium

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 1, 2009, Pages 19-27

  Tsurubuchi, Takao ^a   Zoboronok, Alexander ^a   Yamamoto, Tetsuya ^a   Nakai, Kei ^a   Yoshida, Fumiyo ^a   Shirakawa, Makoto ^b   Matsuda, Masahide ^a   Matsumura, Akira ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE   (Japan)

Author keywords

Brain; Glioma; PD; PDT Rat model

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; TALAPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN TUMOR; COLD INJURY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; FLUORESCENCE IMAGING; GLIOMA; IN VIVO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 67349162676     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2016.12.008     Document Type: Erratum

References (54)

1. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 10 (2005) 987-996
2. Gaspar L.E., Fisher B.J., Macdonald D.R., et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24 1 (1992) 55-57
3. Oppitz U., Maessen D., Zunterer H., Richter S., and Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 53 1 (1999) 53-57
4. Wallner K.E., Galicich J.H., Krol G., Arbit E., and Malkin M.G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16 6 (1989) 1405-1409
5. Albert F.K., Forsting M., Sartor K., et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34 (1994) 45-61
6. Kowalczuk A., Macdonald R.L., Amidei C., et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41 (1997) 1028-1038
7. Schrieve D.C., Alexander E.I.I.I., Black P.M., et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90 (1999) 72-77
8. Wood J.R., Green S.B., and Shapiro W.R. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6 (1988) 338-343
9. Eljamel M.S., Good man C., and Moseley H. ALA and photofrin(R) fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre phase III randomised controlled trial. Lasers Med Sci 23 (2008) 361-367
10. Moseley H., McLean C., Hockaday S., and Eljamel S. In vitro light distributions from intracranial PDT balloons. Photodiag Photodyn Ther 4 (2007) 213-220
11. Eljamel M.S. Brain PDD and PDT unlocking the mystery of malignant gliomas. Photodiag Photodyn Ther 1 (2005) 303-310
12. Eljamel M.S. Photodynamic assisted surgical resection and treatment of malignant brain tumours technique, technology and clinical application. Photodiag Photodyn Ther 1 (2004) 93-98
13. Eljamel M.S. New light on the brain: The role of photosensitising agents and laser light in the management of invasive intracranial tumours. Technol Cancer Res Treat 2 4 (2003) 303-309
14. Kostron H., Bellnier D.A., Lin C.W., Swartz M.R., and Maturza R.L. Distribution, retention, and phototoxicity of hematoporphyrin derivate in rat glioma: intraneoplastic versus intraperitoneal injection. J Neurosurg 64 (1986) 768-774
15. Lilge L., and Wilson B.C. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg 16 2 (1998) 81-91
16. Yang V.X., Muller P.J., Herman P., and Wilson B.C. A multispectral fluorescence imaging system: design and initial clinical tests in intra-operative photofrin-photodynamic therapy of brain tumors. Lasers Surg Med 32 3 (2003) 224-232
17. Schmidt M.H., Bajic D.M., Reichert II K.W., Martin T.S., Meyer G.A., and Whelan H.T. Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery 38 3 (1996) 552-557
18. Stummer W., Stocker S., Novotony A., et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45 (1998) 160-169
19. Stummer W., Novotny A.C., Stepp H., Goetz C., Bise K., and Reulen H.J. Fluorescene-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93 (2000) 1003-1013
20. Kaye A.H., Morstyn G., and Ashcroft R.G. Uptake and retention of hematoporphyrin derivate in an in vivo/vitro models of cerebral glioma. Neurosurgery 17 (1985) 883-890
21. Wise B.L., and Taxdal D.R. Studies of the blood-brain barrier utilizing hematoporphyrin. Brain Res 4 (1967) 387-389
22. Goetz C., Hasan A., Stummer W., Heimann A., and Kempski O. Experimental research photodynamic effects in perifocal, oedematous brain tissue. Acta Neurochir (Wien) 144 2 (2002) 173-179
23. Kostron H., Fitsch E., and Grunert V. Photodynamic therapy of malignant brain tumours: a phase I/II trial. Br J Neurosurg 2 2 (1988) 241-248
24. Stummer W., Gotz C., Hassan A., Heimann A., and Kempski O. Kinetics of photofrin II in perifocal brain edema. Neurosurgery 33 (1993) 1075-1081
25. Schmidt M.H., Reichert II K.W., Ozker K., et al. Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors. Pediatr Neurosurg 30 5 (1999) 225-231
26. Hill J.S., Kahl S.B., Kaye A.H., et al. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A 89 5 (1992) 1785-1789
27. 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolevulinic acid in the C6 rat glioma model. Br J Cancer 78 (1998) 733-738
28. Regula J., MacTobert A.J., Gorchein A., et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5-aminolevulinic acid induced protoporphyrin IX-a pilot study. Gut 36 (1995) 67-75
29. Stummer W., Pichlmeier U., Meinel T., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7 5 (2006) 392-401
30. Angell-Petersen E., Spetalen S., Madsen S.J., et al. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg 104 1 (2006) 109-117
31. Hirschberg H., Sørensen D.R., Angell-Petersen E., et al. Repetitive photodynamic therapy of malignant brain tumors. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 261-279
32. Madsen S.J., Sun C.H., Tromberg B.J., Wallace V.P., and Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid. Photochem Photobiol 72 (2000) 128-134
33. Miyatake S., Kuroiwa T., Kajimoto Y., Miyashita M., Tanaka H., and Tsuji M. Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report. Neurosurgery 61 (2007) 1101-1104
34. Utsuki S., Oka H., Sato S., et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo) 47 (2007) 210-214
35. Bothe H.E., Bodsch W., and Hossmann K.A. Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema. Acta Neuropathol (Berl) 64 (1984) 37-42
36. Klatzo I., Piraux A., and Laskowski E.J. The relationship between edema, blood-brain-barrier and tissue elements in a local brain injury. J Neuropathol Exp Neurol 17 (1958) 548-564
37. Olivo M., and Wilson B.C. Mapping ALA-induced PpIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy. Int J Oncol 5 (2004) 37-45
38. van den Boogert J.R., Van Hillegersberg F.W.M., de Rooji R.W.F., et al. Tilanus 5-aminolevulinic acid-induced protoporphyrin accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B 44 (1998) 29-38
39. Hebeda K.M., Saarnak A.E., Olivo M., Sterenborg H.J.C.M., and Wolbers J.G. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir (Wien) 140 (1998) 503-513
40. Loh C.S., MacRobert A.J., Bedwell J., Regula J., Krasner N., and Bown S.G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 68 1 (1993) 41-51
41. Henderson B.W., Vaughan L., Bellnier D.A., van Leengoed H., Johnson P.G., and Oseroff A.R. Photosensitization of murine tumor, vasculature and skin by using 5-aminolevulinic acid-induced porphyrin. Photochem Photobiol 62 (1995) 780-789
42. Gomer C.J., and Ferrario A. Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 50 (1990) 3985-3990
43. Matsumura H., Akimoto J., Haraoka J., and Aizawa K. Uptake and retention of photosensitizer mono-l-asparthyl chlorine e6 in experimental malignant glioma. Lasers Med Sci 23 3 (2008) 237-245
44. Long D.M. Microvascular changes in cold injury edema. In: Go K.G., and Baethman A. (Eds). Recent progress in the study and therapy of brain edema (1984), Plenum, New York 45-54
45. Nag S. FRCPC cold-injury of the cerebral cortex: immunolocalization of cellular proteins and blood-brain barrier permeability studies. J Neuropathol Exp Neurol 55 (1996) 880-888
46. Klatzo I., Wisniewski H., and Smith D.E. Observations on penetration of serum proteins into the cerebral nervous system. Prog Brain Res 15 (1965) 73-88
47. Reulen H.J., Graham R., Spatz M., and Klatzo I. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg 46 (1977) 24-35
48. Friesen S.A., Hjortland G.O., Madsen S.J., et al. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). Int J Oncol 21 3 (2002) 577-582
49. Novotony A., Xiang J., Stummer W., Teuscher N.S., Smith D.E., and Keep R.F. Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem 75 1 (2000) 321-328
50. Wu S.M., Ren O.G., Zhou M.O., Peng Q., and Chen J.Y. Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevuloinic acid and its hexylester. Cancer Lett 200 2 (2003) 123-131
51. Henderson B.W., and Bellnier D.A. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found Symp 146 (1989) 112-130
52. Hirschberg H., Spetalen S., Carper S., Hole P., Tillung T., and Madsen S. Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma. Minim Invasive Neurosurg 49 3 (2006) 135-142
53. Gaab M.R., Poch B., and Heller V. Oxygen tension, oxygen metabolism, and microcirculation in vaogenic brain edema. Adv Neurol 52 (1990) 247-256
54. Itabashi Y., Prado G.L.M., Abo M., Miura H., and Abe Y. Dissociation of brain edema induced by cold injury in rat model: MR imaging and perfusion studies with 14C-iodo-antipyrine. Ann Nucl Med 15 4 (2001) 337-342